“We have an interest in using this and connected molecules to handle chronic pain in the clinic. Clearly, the interest is in using the compounds by themselves, on condition that they don't generate the sedation attribute of dexmedetomidine, which is a fantastic drug, but one that is largely restricted https://thejillist.com/story6453776/how-the-new-pain-kille-conolidine-can-save-you-time-stress-and-money